For investors keen on the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents an intriguing opportunity, particularly with its potential upside of 72.62%, as indicated by the current analyst ratings. With a focus on medical technology, AngioDynamics designs, manufactures, and sells a range of advanced medical devices, making it a significant player in the treatment of peripheral vascular disease and oncology.

#### Company Performance and Financial Health

AngioDynamics, with a market capitalization of $461.63 million, has captured investor attention due to its robust revenue growth of 9.00%. Despite the absence of a trailing P/E ratio and a forward P/E of -101.82, the company shows promising long-term potential. However,…